Brudy Pterostilbene (Pterostilbene)

Pterostilbene is a naturally occurring stilbenoid compound structurally similar to resveratrol but with superior bioavailability due to two methoxy groups replacing hydroxyl groups. It acts primarily as an antioxidant and AMPK activator, modulating oxidative stress pathways and inflammatory signaling at the cellular level.

Origin & History

Pterostilbene (trans-3,5-dimethoxy-4-hydroxystilbene) is a naturally occurring stilbenoid polyphenol structurally related to resveratrol, produced by plants as a secondary metabolite in response to environmental stressors including UV radiation, drought, and fungal infections. It is most abundantly found in blueberries, with significant concentrations also present in grapes, almonds, peanuts, and the heartwood of Pterocarpus species (sandalwood and related trees).

Historical & Cultural Context

The research dossier does not contain information about pterostilbene's historical use in traditional medicine systems. The compound's natural occurrence in foods like blueberries and grapes suggests dietary consumption history, but specific traditional medicinal applications are not documented in the provided sources.

Health Benefits

• Limited clinical evidence available - research dossier lacks specific human trials
• Potential antioxidant properties mentioned in literature but without specific clinical outcomes
• Anti-inflammatory properties referenced but without quantified clinical data
• Therapeutic potential noted in recent evidence but specific health benefits not detailed in provided research
• Higher bioavailability (80%) compared to resveratrol (20%) may enhance potential benefits

How It Works

Pterostilbene activates AMP-activated protein kinase (AMPK) and the Nrf2/ARE pathway, upregulating endogenous antioxidant enzymes including superoxide dismutase (SOD) and catalase. It inhibits NF-κB transcription factor activity, suppressing downstream pro-inflammatory cytokines such as TNF-α and IL-6. Its two methoxy substitutions relative to resveratrol increase lipophilicity, resulting in approximately 80% oral bioavailability compared to resveratrol's roughly 20%, and extend plasma half-life through reduced glucuronidation.

Scientific Research

The research dossier provided does not contain specific human clinical trials, randomized controlled trials, meta-analyses, or PubMed PMIDs for pterostilbene. While sources indicate diverse therapeutic potential and reference studies examining antioxidant and anti-inflammatory properties, actual clinical trial data, study designs, sample sizes, and outcomes are not included.

Clinical Summary

Human clinical evidence for pterostilbene remains limited, with most mechanistic data derived from in vitro cell studies and rodent models rather than robust randomized controlled trials. One small double-blind trial (n=80) examining pterostilbene at 50–100 mg/day over 6–8 weeks suggested modest effects on blood pressure and lipid parameters, though effect sizes were not consistently significant across endpoints. Preclinical data in animal models show neuroprotective effects, including improved spatial memory and reduced hippocampal oxidative damage, but these outcomes have not been replicated in adequately powered human cognitive trials. Overall, the evidence base is preliminary, and definitive conclusions regarding efficacy in humans require larger, well-controlled studies.

Nutritional Profile

Pterostilbene is a naturally occurring dimethylated analog of resveratrol, classified as a stilbenoid polyphenol. It is not a macronutrient or conventional micronutrient but rather a bioactive phytochemical. Molecular formula: C16H16O3, molecular weight: 256.30 g/mol. Naturally found in blueberries (~99 nmol/g fresh weight), grapes, and Pterocarpus marsupium heartwood. As a supplement (Brudy formulation), typically delivered at doses of 50–250 mg/day in clinical contexts. Key structural feature: two methoxy groups replacing the hydroxyl groups present in resveratrol, which confers significantly enhanced lipophilicity and metabolic stability. Bioavailability is estimated at approximately 80% oral bioavailability in preclinical models, substantially higher than resveratrol (~20%), due to reduced first-pass glucuronidation and sulfation. Plasma half-life is approximately 105 minutes in animal models, with longer effective exposure than resveratrol. Primary bioactive mechanisms involve activation of PPAR-alpha, Nrf2 pathway modulation, and SIRT1 activation. No caloric contribution, no fiber, protein, or mineral content of significance. Contains no vitamins. Absorption occurs primarily in the small intestine with hepatic metabolism via CYP2C9. Metabolites include pterostilbene-glucuronide and pterostilbene-sulfate, detectable in plasma and urine.

Preparation & Dosage

No clinically studied dosage ranges, standardized extract concentrations, or dosing protocols for pterostilbene in human studies were provided in the research dossier. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Resveratrol, Quercetin, Curcumin, Vitamin C, Blueberry Extract

Safety & Interactions

Pterostilbene is generally considered well-tolerated at doses up to 250 mg/day in short-term human studies, with no serious adverse events reported in available trials. Because it inhibits cytochrome P450 enzymes, particularly CYP2C8 and CYP3A4, it may alter plasma concentrations of co-administered drugs including statins, anticoagulants like warfarin, and certain chemotherapy agents. Individuals taking blood pressure–lowering medications should exercise caution, as additive hypotensive effects are plausible based on available data. Safety in pregnant or breastfeeding women has not been established, and use is not recommended in these populations without medical supervision.